Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 170

1.

Recent developments in the management of acute and chronic hyponatremia.

Hoorn EJ, Spasovski G.

Curr Opin Nephrol Hypertens. 2019 Jun 20. doi: 10.1097/MNH.0000000000000528. [Epub ahead of print]

PMID:
31232710
2.

Mild cognitive impairment and kidney disease: clinical aspects.

Viggiano D, Wagner CA, Blankestijn PJ, Bruchfeld A, Fliser D, Fouque D, Frische S, Gesualdo L, Gutiérrez E, Goumenos D, Hoorn EJ, Eckardt KU, Knauß S, König M, Malyszko J, Massy Z, Nitsch D, Pesce F, Rychlík I, Soler MJ, Spasovski G, Stevens KI, Trepiccione F, Wanner C, Wiecek A, Zoccali C, Unwin R, Capasso G.

Nephrol Dial Transplant. 2019 Apr 9. pii: gfz051. doi: 10.1093/ndt/gfz051. [Epub ahead of print] No abstract available.

PMID:
31071220
3.

Strong and Sustained Antihypertensive Effect of Small Interfering RNA Targeting Liver Angiotensinogen.

Uijl E, Mirabito Colafella KM, Sun Y, Ren L, van Veghel R, Garrelds IM, de Vries R, Poglitsch M, Zlatev I, Kim JB, Hoorn EJ, Foster D, Danser AHJ.

Hypertension. 2019 Jun;73(6):1249-1257. doi: 10.1161/HYPERTENSIONAHA.119.12703.

PMID:
31030610
4.

Kidney Function and Arterial Calcification in Major Vascular Beds.

Sedaghat S, Hoorn EJ, Ikram MA, Koop-Nieuwelink C, Kavousi M, Franco OH, van der Lugt A, Vernooij MW, Bos D.

J Am Heart Assoc. 2019 May 7;8(9):e010930. doi: 10.1161/JAHA.118.010930.

5.

Diet-dependent acid load - the missing link between an animal protein-rich diet and non-alcoholic fatty liver disease?

Alferink LJM, Kiefte-de Jong JC, Erler NS, de Knegt RJ, Hoorn EJ, Ikram MA, Janssen HLA, Metselaar HJ, Franco OH, Murad SD.

J Clin Endocrinol Metab. 2019 Apr 12. pii: jc.2018-02792. doi: 10.1210/jc.2018-02792. [Epub ahead of print]

PMID:
30977830
6.

NER1006 is clinically safe.

Repici A, Hassan C, Hoorn EJ, Bisschops R.

Gastrointest Endosc. 2019 Apr;89(4):908-909. doi: 10.1016/j.gie.2019.02.004. No abstract available. Erratum in: Gastrointest Endosc. 2019 Jul;90(1):169.

PMID:
30902224
7.

A preliminary survey of practice patterns across several European kidney stone centers and a call for action in developing shared practice.

Ferraro PM, Arrabal-Polo MÁ, Capasso G, Croppi E, Cupisti A, Ernandez T, Fuster DG, Galan JA, Grases F, Hoorn EJ, Knauf F, Letavernier E, Mohebbi N, Moochhala S, Petkova K, Pozdzik A, Sayer J, Seitz C, Strazzullo P, Trinchieri A, Vezzoli G, Vitale C, Vogt L, Unwin RJ, Bonny O, Gambaro G.

Urolithiasis. 2019 Jun;47(3):219-224. doi: 10.1007/s00240-019-01119-z. Epub 2019 Mar 8.

PMID:
30848320
8.

Timing of Parathyroidectomy Does Not Influence Renal Function After Kidney Transplantation.

van der Plas WY, El Moumni M, von Forstner PJ, Koh EY, Dulfer RR, van Ginhoven TM, Rotmans JI, Appelman-Dijkstra NM, Schepers A, Hoorn EJ, Plukker JTM, Vogt L, Engelsman AF, Nieveen van Dijkum EJM, Kruijff S, Pol RA, de Borst MH; Dutch Hyperparathyroidism Study Group.

World J Surg. 2019 Feb 24. doi: 10.1007/s00268-019-04952-w. [Epub ahead of print]

PMID:
30798418
9.

Parathyroidectomy versus cinacalcet for tertiary hyperparathyroidism; a retrospective analysis.

Dulfer RR, Koh EY, van der Plas WY, Engelsman AF, van Dijkum EJMN, Pol RA, Vogt L, de Borst MH, Kruijff S, Schepers A, Appelman-Dijkstra NM, Rotmans JI, Hesselink DA, van Eijck CHJ, Hoorn EJ, van Ginhoven TM; Dutch Hyperparathyroid Study Group.

Langenbecks Arch Surg. 2019 Feb;404(1):71-79. doi: 10.1007/s00423-019-01755-4. Epub 2019 Feb 7.

10.

Iron handling by the human kidney: glomerular filtration and tubular reabsorption both contribute to urinary iron excretion.

van Raaij SEG, Rennings AJ, Biemond BJ, Schols SEM, Wiegerinck ETG, Roelofs HMJ, Hoorn EJ, Walsh SB, Nijenhuis T, Swinkels DW, van Swelm RPL.

Am J Physiol Renal Physiol. 2019 Mar 1;316(3):F606-F614. doi: 10.1152/ajprenal.00425.2018. Epub 2019 Jan 9.

PMID:
30623722
11.

Role of Dietary K+ in Natriuresis, Blood Pressure Reduction, Cardiovascular Protection, and Renoprotection.

Gritter M, Rotmans JI, Hoorn EJ.

Hypertension. 2019 Jan;73(1):15-23. doi: 10.1161/HYPERTENSIONAHA.118.11209. No abstract available.

PMID:
30571564
12.

Current State of Renal Regenerative Therapies.

Shankar AS, Hoorn EJ, Gribnau J, Baan CC, Hoogduijn MJ.

Transplantation. 2019 Feb;103(2):250-261. doi: 10.1097/TP.0000000000002547.

PMID:
30489479
13.

Potassium: poison or panacea in chronic kidney disease?

Yeung SMH, Vogt L, Rotmans JI, Hoorn EJ, de Borst MH.

Nephrol Dial Transplant. 2019 Feb 1;34(2):175-180. doi: 10.1093/ndt/gfy329. No abstract available.

PMID:
30418647
14.

Safety and efficacy of subtotal or total parathyroidectomy for patients with secondary or tertiary hyperparathyroidism in four academic centers in the Netherlands.

van der Plas WY, Dulfer RR, Koh EY, Vogt L, Appelman-Dijkstra NM, Schepers A, Rotmans JI, Pol RA, van Ginhoven TM, Hoorn EJ, Nieveen van Dijkum EJM, Engelsman AF, de Borst MH, Kruijff S; Dutch Hyperparathyroidism Study Group (DHSG).

Langenbecks Arch Surg. 2018 Dec;403(8):999-1005. doi: 10.1007/s00423-018-1726-6. Epub 2018 Nov 10.

15.

Identifying cystogenic paracrine signaling molecules in cyst fluid of patients with polycystic kidney disease.

Kenter AT, van Rossum-Fikkert SE, Salih M, Verhagen PCMS, van Leenders GJLH, Demmers JAA, Jansen G, Gribnau J, Zietse R, Hoorn EJ.

Am J Physiol Renal Physiol. 2019 Jan 1;316(1):F204-F213. doi: 10.1152/ajprenal.00470.2018. Epub 2018 Nov 7.

PMID:
30403162
16.

Renal tubular effects of prolonged therapy with the GLP-1 receptor agonist lixisenatide in patients with type 2 diabetes mellitus.

Tonneijck L, Muskiet MHA, Blijdorp CJ, Smits MM, Twisk JW, Kramer MHH, Danser AHJ, Diamant M, Joles JA, Hoorn EJ, van Raalte DH.

Am J Physiol Renal Physiol. 2019 Feb 1;316(2):F231-F240. doi: 10.1152/ajprenal.00432.2018. Epub 2018 Oct 24.

PMID:
30353743
17.

Yield of diagnostic tests in unexplained renal hypophosphatemia: a case series.

Bech AP, Hoorn EJ, Zietse R, Wetzels JFM, Nijenhuis T.

BMC Nephrol. 2018 Sep 4;19(1):220. doi: 10.1186/s12882-018-1017-z.

18.

Thiazide but not loop diuretics is associated with hypomagnesaemia in the general population.

Kieboom BCT, Zietse R, Ikram MA, Hoorn EJ, Stricker BH.

Pharmacoepidemiol Drug Saf. 2018 Nov;27(11):1166-1173. doi: 10.1002/pds.4636. Epub 2018 Aug 10.

PMID:
30095199
19.

Rationale and Design of a Randomized Placebo-Controlled Clinical Trial Assessing the Renoprotective Effects of Potassium Supplementation in Chronic Kidney Disease.

Gritter M, Vogt L, Yeung SMH, Wouda RD, Ramakers CRB, de Borst MH, Rotmans JI, Hoorn EJ.

Nephron. 2018;140(1):48-57. doi: 10.1159/000490261. Epub 2018 Jun 29.

20.

Mycophenolate Mofetil Attenuates DOCA-Salt Hypertension: Effects on Vascular Tone.

Moes AD, Severs D, Verdonk K, van der Lubbe N, Zietse R, Danser AHJ, Hoorn EJ.

Front Physiol. 2018 May 18;9:578. doi: 10.3389/fphys.2018.00578. eCollection 2018.

21.

Standard process-oriented workflow introduces pre-analytical error when used in large study sample batches.

Kieboom BCT, Hoorn EJ, Ramakers C, van Rooij FJA, Ikram MA, Hofman A, van Duijn CM, Heeringa J, Zietse R, Peeters RP, Stricker BH, de Rijke YB.

Clin Chem Lab Med. 2018 Nov 27;56(12):e277-e279. doi: 10.1515/cclm-2018-0295. No abstract available.

PMID:
29858899
22.

Personalized dynamic risk assessment in nephrology is a next step in prognostic research.

Brankovic M, Kardys I, Hoorn EJ, Baart S, Boersma E, Rizopoulos D.

Kidney Int. 2018 Jul;94(1):214-217. doi: 10.1016/j.kint.2018.04.007. Epub 2018 May 24.

PMID:
29804659
23.

Increased Urinary Extracellular Vesicle Sodium Transporters in Cushing Syndrome With Hypertension.

Salih M, Bovée DM, van der Lubbe N, Danser AHJ, Zietse R, Feelders RA, Hoorn EJ.

J Clin Endocrinol Metab. 2018 Jul 1;103(7):2583-2591. doi: 10.1210/jc.2018-00065.

PMID:
29726949
24.

Kidney function, gait pattern and fall in the general population: a cohort study.

Sedaghat S, Darweesh SKL, Verlinden VJA, van der Geest JN, Dehghan A, Franco OH, Hoorn EJ, Ikram MA.

Nephrol Dial Transplant. 2018 Dec 1;33(12):2165-2172. doi: 10.1093/ndt/gfy043.

PMID:
29566168
25.

A Successful Approach to Kidney Transplantation in Patients With Enteric (Secondary) Hyperoxaluria.

Roodnat JI, de Mik-van Egmond AME, Visser WJ, Berger SP, van der Meijden WAG, Knauf F, van Agteren M, Betjes MGH, Hoorn EJ.

Transplant Direct. 2017 Nov 8;3(12):e331. doi: 10.1097/TXD.0000000000000748. eCollection 2017 Dec.

26.

Nutritional Management of Chronic Kidney Disease.

Hoorn EJ, Vogt L, Rotmans JI.

N Engl J Med. 2018 Feb 8;378(6):583-4. doi: 10.1056/NEJMc1715765. No abstract available.

PMID:
29419275
27.

Effects of a high-sodium/low-potassium diet on renal calcium, magnesium, and phosphate handling.

van der Wijst J, Tutakhel OAZ, Bos C, Danser AHJ, Hoorn EJ, Hoenderop JGJ, Bindels RJM.

Am J Physiol Renal Physiol. 2018 Jul 1;315(1):F110-F122. doi: 10.1152/ajprenal.00379.2017. Epub 2018 Jan 10.

PMID:
29357414
28.

Effect of immediate and prolonged GLP-1 receptor agonist administration on uric acid and kidney clearance: Post-hoc analyses of four clinical trials.

Tonneijck L, Muskiet MHA, Smits MM, Bjornstad P, Kramer MHH, Diamant M, Hoorn EJ, Joles JA, van Raalte DH.

Diabetes Obes Metab. 2018 May;20(5):1235-1245. doi: 10.1111/dom.13223. Epub 2018 Feb 20.

29.

[Hydration to prevent contrast-induced nephropathy].

Hoorn EJ, Zietse R.

Ned Tijdschr Geneeskd. 2018;161:D2442. Dutch.

PMID:
29328017
30.

Limited salt consumption reduces the incidence of chronic kidney disease: a modeling study.

Hendriksen MAH, Over EAB, Navis G, Joles JA, Hoorn EJ, Gansevoort RT, Boshuizen HC.

J Public Health (Oxf). 2018 Sep 1;40(3):e351-e358. doi: 10.1093/pubmed/fdx178.

PMID:
29325124
32.

Effects of Thyroid Hormone on Urinary Concentrating Ability.

Massolt ET, Salih M, Beukhof CM, Kam BLR, Burger JW, Visser WE, Hoorn EJ, Peeters RP.

Eur Thyroid J. 2017 Sep;6(5):238-242. doi: 10.1159/000478521. Epub 2017 Jul 3.

33.

Renal physiology: Prostaglandins in thiazide-induced hyponatraemia: do they hold water?

Hoorn EJ, Wetzels JFM.

Nat Rev Nephrol. 2017 Nov;13(11):665-666. doi: 10.1038/nrneph.2017.133. Epub 2017 Sep 25. No abstract available.

PMID:
28944774
34.

Serum magnesium is associated with the risk of dementia.

Kieboom BCT, Licher S, Wolters FJ, Ikram MK, Hoorn EJ, Zietse R, Stricker BH, Ikram MA.

Neurology. 2017 Oct 17;89(16):1716-1722. doi: 10.1212/WNL.0000000000004517. Epub 2017 Sep 20.

PMID:
28931641
35.

GLP-1 and the kidney: from physiology to pharmacology and outcomes in diabetes.

Muskiet MHA, Tonneijck L, Smits MM, van Baar MJB, Kramer MHH, Hoorn EJ, Joles JA, van Raalte DH.

Nat Rev Nephrol. 2017 Oct;13(10):605-628. doi: 10.1038/nrneph.2017.123. Epub 2017 Sep 4. Review.

PMID:
28869249
36.

Urinary renin-angiotensin markers in polycystic kidney disease.

Salih M, Bovée DM, Roksnoer LCW, Casteleijn NF, Bakker SJL, Gansevoort RT, Zietse R, Danser AHJ, Hoorn EJ.

Am J Physiol Renal Physiol. 2017 Oct 1;313(4):F874-F881. doi: 10.1152/ajprenal.00209.2017. Epub 2017 Jul 26.

37.

A Missense Mutation in the Extracellular Domain of αENaC Causes Liddle Syndrome.

Salih M, Gautschi I, van Bemmelen MX, Di Benedetto M, Brooks AS, Lugtenberg D, Schild L, Hoorn EJ.

J Am Soc Nephrol. 2017 Nov;28(11):3291-3299. doi: 10.1681/ASN.2016111163. Epub 2017 Jul 14.

38.

Acute kidney injury after liver transplantation: Recent insights and future perspectives.

de Haan JE, Hoorn EJ, de Geus HRH.

Best Pract Res Clin Gastroenterol. 2017 Apr;31(2):161-169. doi: 10.1016/j.bpg.2017.03.004. Epub 2017 Apr 12. Review.

PMID:
28624104
39.

Hyponatraemia diagnosis and treatment clinical practice guidelines.

Spasovski G, Vanholder R, Allolio B, Annane D, Ball S, Bichet D, Decaux G, Fenske W, Hoorn EJ, Ichai C, Joannidis M, Soupart A, Zietse R, Haller M, van der Veer S, van Biesen W, Nagler E, Gonzalez-Espinoza L, Ortiz A; Hyponatraemia Guideline Development Group.

Nefrologia. 2017 Jul - Aug;37(4):370-380. doi: 10.1016/j.nefro.2017.03.021. Epub 2017 Jun 12. English, Spanish.

40.

Systematic review of surgical and medical treatment for tertiary hyperparathyroidism.

Dulfer RR, Franssen GJH, Hesselink DA, Hoorn EJ, van Eijck CHJ, van Ginhoven TM.

Br J Surg. 2017 Jun;104(7):804-813. doi: 10.1002/bjs.10554. Review.

PMID:
28518414
41.

NaCl cotransporter abundance in urinary vesicles is increased by calcineurin inhibitors and predicts thiazide sensitivity.

Tutakhel OAZ, Moes AD, Valdez-Flores MA, Kortenoeven MLA, Vrie MVD, Jeleń S, Fenton RA, Zietse R, Hoenderop JGJ, Hoorn EJ, Hilbrands L, Bindels RJM.

PLoS One. 2017 Apr 21;12(4):e0176220. doi: 10.1371/journal.pone.0176220. eCollection 2017.

42.

Autophagy and renal epithelial transport: eat to survive.

Hoorn EJ, Severs D.

Kidney Int. 2017 May;91(5):1003-1005. doi: 10.1016/j.kint.2017.01.033.

PMID:
28407874
43.

Ferric carboxymaltose-induced hypophosphataemia after kidney transplantation.

Sari V, Atiqi R, Hoorn EJ, Heijboer AC, van Gelder T, Hesselink DA.

Neth J Med. 2017 Mar;75(2):65-73.

44.

Chlorthalidone Versus Amlodipine for Hypertension in Kidney Transplant Recipients Treated With Tacrolimus: A Randomized Crossover Trial.

Moes AD, Hesselink DA, van den Meiracker AH, Zietse R, Hoorn EJ.

Am J Kidney Dis. 2017 Jun;69(6):796-804. doi: 10.1053/j.ajkd.2016.12.017. Epub 2017 Mar 1.

PMID:
28259499
45.

Serum magnesium and the risk of prediabetes: a population-based cohort study.

Kieboom BCT, Ligthart S, Dehghan A, Kurstjens S, de Baaij JHF, Franco OH, Hofman A, Zietse R, Stricker BH, Hoorn EJ.

Diabetologia. 2017 May;60(5):843-853. doi: 10.1007/s00125-017-4224-4. Epub 2017 Feb 21.

46.

Diagnosis and Treatment of Hyponatremia: Compilation of the Guidelines.

Hoorn EJ, Zietse R.

J Am Soc Nephrol. 2017 May;28(5):1340-1349. doi: 10.1681/ASN.2016101139. Epub 2017 Feb 7. Review.

47.

[Fatal cerebral oedema during the treatment of diabetic ketoacidosis in an adult male].

Dekker TJ, Janson JA, Hoorn EJ, Sijpkens YW.

Ned Tijdschr Geneeskd. 2017;161:D734. Dutch.

PMID:
28145211
48.

The association of thyroid function and the risk of kidney function decline: a population-based cohort study.

Chaker L, Sedaghat S, Hoorn EJ, Elzen WP, Gussekloo J, Hofman A, Ikram MA, Franco OH, Dehghan A, Peeters RP.

Eur J Endocrinol. 2016 Dec;175(6):653-660.

PMID:
27926474
49.

Intravenous fluids: balancing solutions.

Hoorn EJ.

J Nephrol. 2017 Aug;30(4):485-492. doi: 10.1007/s40620-016-0363-9. Epub 2016 Nov 29. Review.

50.

Differential diagnosis of hyponatraemia: moving forward?

Hoorn EJ.

Clin Endocrinol (Oxf). 2017 Mar;86(3):315-316. doi: 10.1111/cen.13276. Epub 2016 Nov 28. No abstract available.

PMID:
27862139

Supplemental Content

Loading ...
Support Center